IL-22 regulation of functional gene expression in salivary gland cells

Genomics Data

Volumn 7, Issue , 2016, Pages 178-184

  Lavoie, Tegan N ^a,d   Carcamo, Wendy C ^a,e   Wanchoo, Arun ^a   Sharma, Ashok ^b   Gulec, Afife ^a   Berg, Kathleen M ^c   Stewart, Carol M ^c   Nguyen, Cuong Q ^a,c  

^a University of Florida   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokine; Gene expression; IL 22; Microarray; Sjogren's syndrome

Indexed keywords

BETA DEFENSIN 1; CARBONATE DEHYDRATASE IX; CHAPERONIN 60; EARLY GROWTH RESPONSE FACTOR 1; GELATINASE B; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 8; RHEUMATOID FACTOR; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGAMMAGLOBULINEMIA; HYPOSALIVATION; IMMUNOMODULATION; MICROARRAY ANALYSIS; MTT ASSAY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY GLAND; SJOEGREN SYNDROME; TRANSCRIPTOMICS; UPREGULATION; WESTERN BLOTTING;

EID: 84953923439     PISSN: 22135960     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gdata.2015.11.014     Document Type: Article

References (41)

1. Fox R.I. Sjogren's syndrome. Lancet 2005, 366:321-331.
2. Nguyen C.Q., Peck A.B. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul. Surf. 2009, 7:11-27.
3. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., Daniels T.E., Fox P.C., Fox R.I., Kassan S.S., Pillemer S.R., Talal N., Weisman M.H. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann. Rheum. Dis. 2002, 61:554-558.
4. Nguyen C.Q., Hu M.H., Li Y., Stewart C., Peck A.B. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice. Arthritis Rheum. 2008, 58:734-743.
5. Lavoie T.N., Stewart C.M., Berg K.M., Li Y., Nguyen C.Q. Expression of interleukin-22 in Sjogren's syndrome: significant correlation with disease parameters. Scand. J. Immunol. 2011, 74:377-382.
6. Ciccia F., Guggino G., Rizzo A., Ferrante A., Raimondo S., Giardina A., Dieli F., Campisi G., Alessandro R., Triolo G. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. Ann. Rheum. Dis. 2012, 71:295-301.
7. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
8. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
9. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009, 31:15-23.
10. Kotenko S.V., Izotova L.S., Mirochnitchenko O.V., Esterova E., Dickensheets H., Donnelly R.P., Pestka S. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem. 2001, 276:2725-2732.
11. Witte E., Witte K., Warszawska K., Sabat R., Wolk K. Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine Growth Factor Rev. 2010, 21:365-379.
12. Xie M.H., Aggarwal S., Ho W.H., Foster J., Zhang Z., Stinson J., Wood W.I., Goddard A.D., Gurney A.L. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 2000, 275:31335-31339.
13. Lejeune D., Dumoutier L., Constantinescu S., Kruijer W., Schuringa J.J., Renauld J.C. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 2002, 277:33676-33682.
14. Vivier E., Spits H., Cupedo T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?. Nat. Rev. Immunol. 2009, 9:229-234.
15. Ikeuchi H., Kuroiwa T., Hiramatsu N., Kaneko Y., Hiromura K., Ueki K., Nojima Y. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 2005, 52:1037-1046.
16. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., Diepolder H., Marquardt A., Jagla W., Popp A., Leclair S., Herrmann K., Seiderer J., Ochsenkuhn T., Goke B., Auernhammer C.J., Dambacher J. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G827-G838.
17. Whittington H.A., Armstrong L., Uppington K.M., Millar A.B. Interleukin-22: a potential immunomodulatory molecule in the lung. Am. J. Respir. Cell Mol. Biol. 2004, 31:220-226.
18. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., Reinhart T.A., McAllister F., Edeal J., Gaus K., Husain S., Kreindler J.L., Dubin P.J., Pilewski J.M., Myerburg M.M., Mason C.A., Iwakura Y., Kolls J.K. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 2008, 14:275-281.
19. Katz J., Blake E., Medrano T.A., Sun Y., Shiverick K.T. Isoflavones and gamma irradiation inhibit cell growth in human salivary gland cells. Cancer Lett. 2008, 270:87-94.
20. Nguyen C.Q., Sharma A., Lee B.H., She J.X., McIndoe R.A., Peck A.B. Differential gene expression in the salivary gland during development and onset of xerostomia in Sjogren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Arthritis Res. Ther. 2009, 11:R56.
21. Nguyen C.Q., Sharma A., She J.X., McIndoe R.A., Peck A.B. Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjogren's syndrome (SJS)-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Exp. Eye Res. 2009, 88:398-409.
22. Dessau R.B., Pipper C.B. ''R"-project for statistical computing. Ugeskr. Laeger 2008, 170:328-330.
23. Fernando R.L., Nettleton D., Southey B.R., Dekkers J.C., Rothschild M.F., Soller M. Controlling the proportion of false positives in multiple dependent tests. Genetics 2004, 166:611-619.
24. Falcon S., Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23:257-258.
25. Hjelmervik T.O., Petersen K., Jonassen I., Jonsson R., Bolstad A.I. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum. 2005, 52:1534-1544.
26. Nagalakshmi M.L., Rascle A., Zurawski S., Menon S., de Waal Malefyt R. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 2004, 4:679-691.
27. Jonsson M.V., Skarstein K., Jonsson R., Brun J.G. Serological implications of germinal center-like structures in primary Sjogren's syndrome. J. Rheumatol. 2007, 34:2044-2049.
28. Nguyen C.Q., Yin H., Lee B.H., Chiorini J.A., Peck A.B. IL17: potential therapeutic target in Sjogren's syndrome using adenovirus-mediated gene transfer. Lab. Investig. 2011, 91:54-62.
29. Nguyen C.Q., Yin H., Lee B.H., Carcamo W.C., Chiorini J.A., Peck A.B. Pathogenic effect of interleukin-17A in induction of Sjogren's syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res. Ther. 2010, 12:R220.
30. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008, 29:947-957.
31. O'Connor W., Zenewicz L.A., Flavell R.A. The dual nature of T(H)17 cells: shifting the focus to function. Nat. Immunol. 2010, 11:471-476.
32. Radaeva S., Sun R., Pan H.N., Hong F., Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004, 39:1332-1342.
33. Delaleu N., Madureira A.C., Immervoll H., Jonsson R. Inhibition of experimental Sjogren's syndrome through immunization with HSP60 and its peptide amino acids 437-460. Arthritis Rheum. 2008, 58:2318-2328.
34. Ciccia F., Guggino G., Rizzo A., Bombardieri M., Raimondo S., Carubbi F., Cannizzaro A., Sireci G., Dieli F., Campisi G., Giacomelli R., Cipriani P., De Leo G., Alessandro R., Triolo G. Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjogren-associated non-Hodgkin Lymphomas and is regulated by IL-18. Clin. Exp. Immunol. 2015.
35. Shirayama M., Toth A., Galova M., Nasmyth K. APC(Cdc20) promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin Clb5. Nature 1999, 402:203-207.
36. Gutsch R., Kandemir J.D., Pietsch D., Cappello C., Meyer J., Simanowski K., Huber R., Brand K. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology. J. Biol. Chem. 2011, 286:22716-22729.
37. Kim H.S., Jeon Y.K., Ha G.H., Park H.Y., Kim Y.J., Shin H.J., Lee C.G., Chung D.H., Lee C.W. Functional interaction between BubR1 and securin in an anaphase-promoting complex/cyclosomeCdc20-independent manner. Cancer Res. 2009, 69:27-36.
38. Lee M.H., Reynisdottir I., Massague J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 1995, 9:639-649.
39. Stiewe T. The p53 family in differentiation and tumorigenesis. Nat. Rev. Cancer 2007, 7:165-168.
40. Voulgarelis M., Moutsopoulos H.M. Lymphoproliferation in autoimmunity and Sjogren's syndrome. Curr. Rheumatol. Rep. 2003, 5:317-323.
41. Nguyen C.Q., Cha S.R., Peck A.B. Sjögren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies. Front. Biosci. 2007, 12:1767-1789.